Terramycin, the brand name for the antibiotic oxytetracycline, was not pulled from the market due to a single safety scandal or FDA ban. Instead, its human formulations were gradually discontinued over time as newer antibiotics replaced it, manufacturing priorities shifted, and the brand transitioned to veterinary-only use. The ophthalmic ointment, once a household staple for eye infections, is the formulation most people remember and wonder about.
What Terramycin Was Used For
Terramycin belongs to the tetracycline class of antibiotics. It works by blocking protein production inside bacteria, effectively stopping them from growing and multiplying. As a broad-spectrum antibiotic, it was effective against a wide range of bacterial infections, which made it popular for both systemic use (taken by mouth) and topical use, particularly as an eye ointment combining oxytetracycline with polymyxin B sulfate.
The ophthalmic ointment was widely used to treat bacterial conjunctivitis (pink eye), styes, and other surface-level eye infections. It was available over the counter in some countries, which contributed to its widespread recognition. Oral and injectable forms were also used for respiratory infections, urinary tract infections, and skin conditions, though these were prescribed less frequently as newer drugs became available.
Why Human Formulations Disappeared
Several overlapping factors drove Terramycin off pharmacy shelves for human use. None of them involved a dramatic recall.
First, the tetracycline class developed a significant antibiotic resistance problem. Decades of widespread use, both in human medicine and agriculture, meant that many common bacteria stopped responding to oxytetracycline. Newer antibiotics offered better effectiveness against the same infections, making Terramycin increasingly obsolete for human treatment.
Second, the side effect profile of tetracyclines, while manageable, gave prescribers reason to choose alternatives. Tetracyclines cause tooth discoloration in children, sun sensitivity that can lead to severe sunburn-like reactions, and gastrointestinal problems including nausea, vomiting, and diarrhea. Rarer but more serious risks include liver damage, worsening kidney function, esophageal ulcers, and increased pressure around the brain. These aren’t unique to Terramycin, but they apply to the whole drug class and made doctors less inclined to reach for older tetracyclines when better-tolerated options existed.
Third, the manufacturer made a business decision. Pfizer, which produced Terramycin, shifted the brand entirely toward veterinary applications. The product is now labeled explicitly “For Animal Use Only” and “Not for Human Use.” This wasn’t necessarily because the drug became unsafe for people overnight. Pharmaceutical companies routinely discontinue products when sales decline below the point where maintaining FDA-compliant manufacturing, labeling, and distribution remains profitable. With human prescriptions dwindling, the veterinary market became the more viable path for the brand.
The Ophthalmic Ointment Specifically
The Terramycin eye ointment is the product most people search for, often because they remember using it years ago or because they’ve seen it sold for pets and wonder if it’s the same thing. The veterinary version still exists and is widely available at farm supply stores and pet pharmacies. It contains the same active ingredients (oxytetracycline and polymyxin B sulfate), but it is manufactured and regulated under veterinary drug standards, not human pharmaceutical standards.
In some countries, versions of the human ophthalmic ointment have appeared on the market without proper regulatory approval. The Philippine FDA, for example, issued a public health warning in 2022 against unregistered Terramycin ophthalmic ointment products, noting that they had not gone through the agency’s registration process and that their quality, safety, and efficacy could not be guaranteed. This highlights a real risk: products labeled as Terramycin for human use that appear online or in informal markets may not meet pharmaceutical manufacturing standards.
What Replaced Terramycin for Eye Infections
Several antibiotic eye ointments now fill the role Terramycin once played. The most commonly prescribed options include:
- Erythromycin ointment: Treats bacterial conjunctivitis in adults and is routinely given to newborns to prevent eye infections acquired during birth.
- Bacitracin ointment: Used for bacterial eye infections in adults.
- Polymyxin B-bacitracin (Polysporin): A combination antibiotic prescribed for most bacterial eye infections.
- Ciprofloxacin: A fluoroquinolone antibiotic suitable for children over 2 and adults.
- Tobramycin: Effective against a broad range of bacterial eye infections, also suitable for children over 2.
For more stubborn infections or styes that don’t resolve on their own, doctors sometimes prescribe combination ointments that pair an antibiotic with a steroid to reduce inflammation alongside treating the infection.
Can You Still Use the Veterinary Version?
This is the question behind the question for many searchers. The veterinary Terramycin ointment is readily available and inexpensive, and people sometimes apply it to their own eyes based on the logic that it contains the same drug. This is a gamble. Veterinary products are manufactured under different quality controls than human pharmaceuticals. Contaminants, preservatives, or formulation differences that are acceptable for animal use may not be appropriate for human eyes. The concentrations may also differ from what was in the original human product. The fact that a drug shares the same active ingredient does not make the two products interchangeable across species-specific manufacturing standards.